Rheumatoid Arthritis News and Research

Latest Rheumatoid Arthritis News and Research

Vectra DA blood test may help predict patients' response to rheumatoid arthritis therapy

Vectra DA blood test may help predict patients' response to rheumatoid arthritis therapy

Tumor necrosis factor can suppress inflammation, treat rheumatoid arthritis

Tumor necrosis factor can suppress inflammation, treat rheumatoid arthritis

Lilly Phase I multiple myeloma study affirms potential of LY2127399-bortezomib combination

Lilly Phase I multiple myeloma study affirms potential of LY2127399-bortezomib combination

EMA CHMP recommends positive opinion for marketing authorization of Amgen's XGEVA

EMA CHMP recommends positive opinion for marketing authorization of Amgen's XGEVA

CEL-SCI initiates global Multikine Phase III trial for head and neck cancer in Russia

CEL-SCI initiates global Multikine Phase III trial for head and neck cancer in Russia

Thermo Fisher Scientific to acquire Phadia for €2.47 billion

Thermo Fisher Scientific to acquire Phadia for €2.47 billion

Free NYU Physician iPad app now available in iTunes store

Free NYU Physician iPad app now available in iTunes store

Nektar to present new NKTR-102 Phase 2 clinical data in multiple cancers at ASCO annual meeting

Nektar to present new NKTR-102 Phase 2 clinical data in multiple cancers at ASCO annual meeting

Amgen announces primary results from XGEVA Phase 3 trial in castrate-resistant prostate cancer

Amgen announces primary results from XGEVA Phase 3 trial in castrate-resistant prostate cancer

CEL-SCI initiates Multikine Phase III trial for head and neck cancer in Canada

CEL-SCI initiates Multikine Phase III trial for head and neck cancer in Canada

ProBioGen, Life Technologies' new cell line development kits now available for biologic drug production

ProBioGen, Life Technologies' new cell line development kits now available for biologic drug production

CEL-SCI initiates Multikine Phase III trial for head and neck cancer in Poland

CEL-SCI initiates Multikine Phase III trial for head and neck cancer in Poland

GSK, AstraZeneca and University of Manchester create new collaborative centre for inflammation research

GSK, AstraZeneca and University of Manchester create new collaborative centre for inflammation research

Journal of Rheumatology publishes positive results from Cimzia Phase III trial in RA

Journal of Rheumatology publishes positive results from Cimzia Phase III trial in RA

Pepscan, Phylogica collaborate for Phylomer peptide lead optimisation

Pepscan, Phylogica collaborate for Phylomer peptide lead optimisation

Charisela develops breakthrough adiponectin assay

Charisela develops breakthrough adiponectin assay

Antares Pharma first quarter total revenues increase to $3.6 million

Antares Pharma first quarter total revenues increase to $3.6 million

POZEN reports revenue of $4.5 million for first quarter 2011

POZEN reports revenue of $4.5 million for first quarter 2011

Grant Thornton Leader & Innovator of the Year award for Diplomat Specialty Pharmacy president

Grant Thornton Leader & Innovator of the Year award for Diplomat Specialty Pharmacy president

Merck first quarter sales increase 1% to $11.6 billion for 2011

Merck first quarter sales increase 1% to $11.6 billion for 2011

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.